Autoantibodies against type I IFNs in patients with life-threatening COVID-19
…, E Michailidis, HH Hoffmann, Y Zhang, K Dorgham… - Science, 2020 - science.org
INTRODUCTION Interindividual clinical variability is vast in humans infected with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ranging from silent infection to rapid …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ranging from silent infection to rapid …
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
…, Q Philippot, M Chbihi, L Bonnet-Madin, K Dorgham… - Science, 2020 - science.org
INTRODUCTION Clinical outcomes of human severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) infection range from silent infection to lethal coronavirus disease 2019 (…
2 (SARS-CoV-2) infection range from silent infection to lethal coronavirus disease 2019 (…
IgA dominates the early neutralizing antibody response to SARS-CoV-2
…, JM Lacorte, H Yssel, C Parizot, K Dorgham… - Science translational …, 2021 - science.org
Humoral immune responses are typically characterized by primary IgM antibody responses
followed by secondary antibody responses associated with immune memory and composed …
followed by secondary antibody responses associated with immune memory and composed …
Global natural regulatory T cell depletion in active systemic lupus erythematosus
…, C Parizot, C Badoual, K Dorgham… - The Journal of …, 2005 - journals.aai.org
The immune defect that could account for the multisystemic involvement that characterizes
systemic lupus erythematosus (SLE) remains unknown. We hypothesized that iterative …
systemic lupus erythematosus (SLE) remains unknown. We hypothesized that iterative …
The immune paradox of sarcoidosis and regulatory T cells
Sarcoidosis is characterized by extensive local inflammation (granuloma, cytokine secretion)
associated with anergy (poor response to antigens in vitro and in vivo). We postulated that …
associated with anergy (poor response to antigens in vitro and in vivo). We postulated that …
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths
…, R Halwani, NS Sharif-Askari, K Dorgham… - Science …, 2021 - science.org
Circulating autoantibodies (auto-Abs) neutralizing high concentrations (10 ng/ml; in plasma
diluted 1:10) of IFN-α and/or IFN-ω are found in about 10% of patients with critical COVID-19 …
diluted 1:10) of IFN-α and/or IFN-ω are found in about 10% of patients with critical COVID-19 …
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
…, FS Sharif-Askari, K Dorgham… - Proceedings of the …, 2022 - National Acad Sciences
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection fatality rate (IFR)
doubles with every 5 y of age from childhood onward. Circulating autoantibodies neutralizing …
doubles with every 5 y of age from childhood onward. Circulating autoantibodies neutralizing …
[HTML][HTML] Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers
…, D Planas, A Gothland, A Jary, K Dorgham… - Nature …, 2021 - nature.com
There are only few data concerning persistence of neutralizing antibodies (NAbs) among
SARS-CoV-2-infected healthcare workers (HCW). These individuals are particularly exposed …
SARS-CoV-2-infected healthcare workers (HCW). These individuals are particularly exposed …
Microbial ecology perturbation in human IgA deficiency
…, D Sterlin, C Juste, C Parizot, K Dorgham… - Science translational …, 2018 - science.org
Paradoxically, loss of immunoglobulin A (IgA), one of the most abundant antibodies, does not
irrevocably lead to severe infections in humans but rather is associated with relatively mild …
irrevocably lead to severe infections in humans but rather is associated with relatively mild …
CD4+ T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosis
M Février, K Dorgham, A Rebollo - Viruses, 2011 - mdpi.com
Human immunodeficiency virus (HIV) infection is principally a mucosal disease and the
gastrointestinal (GI) tract is the major site of HIV replication. Loss of CD4+ T cells and systemic …
gastrointestinal (GI) tract is the major site of HIV replication. Loss of CD4+ T cells and systemic …